Sort by:

select Language:

Surveillance for Zika virus infection, microcephaly and Guillain-Barré syndrome. Interim guidance

World Health Organization, (2016)

This document provides interim recommendations for the surveillance of Zika virus infection, microcephaly and Guillain-Barré syndrome, in four different contexts and describes reporting requirements to WHO. Transmission refers to vector-borne transmission, unless specified differently. Autochthonous infection is considered to be an infection acquired in-country, i.e. among patients with no history of travel during the incubation period or who have travelled exclusively to non-affected areas during the incubation period. This document does not provide guidance on laboratory investigation or vector surveillance.

Interim guidance for healthcare providers and Zika virus laboratory diagnosis

European Centre for Disease Prevention and Control, (2016)

This document aims to present an algorithm for deciding whom to test and provide guidance on the laboratory tests for Zika virus infection diagnosis in order to support clinical diagnostic and case reporting through surveillance among EU Member States. The algorithm is not intended for clinical management of patients with suspected Zika virus infection. The information is provisional and subject to revision when new information becomes available.

Case definition

European Centre for Disease Prevention and Control, (2016)

ECDC proposed case definition for surveillance of Zika virus infection

Protocolo de Vigilância e Resposta à Ocorrência de Microcefalia e/ou Alterações do Sistema Nervoso Central

Ministério da Saúde Brasil, (2016)

Versão 2. Última atualização 10 Março 2016 O protocolo contém orientações sobre definição de casos suspeitos, como identificação de alterações do Sistema Nervoso Central (SNC) durante a gestação, critérios para confirmação ou descarte de casos, sistema de notificação e investigação laboratorial. Além disso, há orientações sobre como deve ser feita a investigação epidemiológica dos casos suspeitos e sobre o monitoramento e análise de dados.

Birth defects surveillance training: facilitator's guide

World Health Organization (WHO), National Center on Birth Defects and Developmental Disabilities from the United States Centers for Disease Control and Prevention (CDC), International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR), (2015)

The goal of this course is to provide participants with the foundational skills needed to begin the development, implementation and ongoing improvement of a congenital anomalies surveillance programme, in particular for countries with limited resources. It focuses on the methodology needed to develop either population-based or hospital based surveillance programmes. A set of congenital anomalies will be used as examples throughout this course. The specific examples used are typically severe enough that they would probably be captured within the first few days after birth, have a significant public health impact and, for some of them, have the potential for primary prevention.

9 hits